Coverage debates often return to scheduling and bans. India and The us both of those confront versions of a similar issue: irrespective of whether to impose broader, class-huge controls more than fentanyl analogs and their precursors, or to keep substance-by-substance scheduling that could lag at the rear of traffickers’ innovation. https://aristotler257xbh6.wiki-cms.com/user